v3.26.3
SEGMENT INFORMATION - Schedule of Enterprise-Wide Information (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Net Sales by Major Product Group        
Net sales $ 1,715.5 $ 1,553.1 $ 5,105.1 $ 4,498.0
Transcatheter Aortic Valve Replacement        
Net Sales by Major Product Group        
Net sales 1,241.6 1,149.9 3,697.2 3,327.4
Transcatheter Mitral and Tricuspid Therapies        
Net Sales by Major Product Group        
Net sales 209.5 145.2 583.2 394.9
Surgical        
Net Sales by Major Product Group        
Net sales $ 264.4 $ 258.0 $ 824.7 $ 775.7